Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Assess which Sp 500 fund is best for IRAs in 2024 using simple criteria, performance context, and fee awareness for smarter selection.
24,414 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Zircuit Finance unveils an institutional-grade on-chain yield vault designed to deliver 8-11% APR, combining cross-ch...
JPMorgan and Mastercard joined Ripple and Ondo Finance to settle a tokenized US Treasury redemption on the XRP Ledger...
Cloud giants are expanding, yet the super micro computer stock slid on a capital-raise plan. This article breaks down...
A new defense-focused ETF began trading in July 2026, joining VistaShares’ space and robotics funds as investors chas...
Structure Therapeutics stock 187% gains over the last year drew attention from value seekers and momentum players ali...
BridgeBio's Q1 2026 earnings narrative is more than quarterly numbers—it's a roadmap for the year ahead. This guide e...
Two aviation ETFs pull in opposite directions: JETS targets airlines and airports, ITA leans into defense and aerospa...
A long-awaited conversation with lasting impact on culture also carries financial lessons. This article breaks down h...
Rising home equity can look like wealth, but it's not a guaranteed windfall. This guide explains how to evaluate your...
Curious about reliable income from your stock holdings without chasing risky growth? This guide explains what Fidelit...
A high-quality, short-duration AAA CLO ETF is drawing attention by offering more income than 3-month Treasuries. For ...